IRX-101 targets a significant need for millions of patients facing vision loss and has the potential to improve the standard of carePositive ...

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the commercial launch of BYOOVIZ® (ranibizumab-nuna), an FDA-approved biosimilar ...

Samsung Bioepis Co., Ltd. today announced the relaunch of BYOOVIZ ® (ranibizumab-nuna) in the United States (US), in partnership with Harrow (Nasdaq: HROW). Harrow became responsible for ...

Following her mother's vision loss, optometrist Sheyva Sigamoney is pursuing a PhD in vision science at Indiana University.

Pakistan, June 16 -- Imran Khan underwent a fifth eye procedure at a government hospital in Islamabad on Monday, the hospital administration said, with doctors reporting signs of clinical improvement ...

Incarcerated former Prime Minister Imran Khan underwent a successful fifth eye procedure in Islamabad, bringing a wave of relief as doctors reported positive signs of clinical improvement.

U.S. Market to Reach USD 2.02 Billion and Europe Market to Hit USD 1.49 Billion by 2035 as Anti-VEGF Therapies Strengthen ...

Background In cavernous sinus dural arteriovenous fistulas (CS-DAVF), ophthalmological symptoms are usually the main clinical presentation, caused by abnormal drainage of the superior ophthalmic vein ...

Explore latest RVO care: faricimab, Eylea HD, and biosimilars that cut injection burden and protect vision from macular edema. Retinal vein occlusion (RVO) is the second most common retinal vascular ...

Intravenous tenecteplase administered within 4.5 hours after onset of central retinal artery occlusion does not improve vision recovery at 30 days compared with oral aspirin, according to a study ...

The idea of an anime-style soulslike releases plenty of good chemicals in my brain, but the first Code Vein back in 2019 turned out to be just okay in my book. Like a number of Bandai Namco's original ...